When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XLRN - Celgene files U.S. application for luspatercept for certain anemias
Acceleron Pharma Inc.
Celgene (CELG+0.3%) has filed a marketing application with the FDA seeking approval for luspatercept for the treatment of adult patients with very-low-to-intermediate-risk myelodysplastic syndromes-associated anemia who have ring sideroblasts and require red blood cell transfusions and for the treatment of adult patients with beta-thalassemia-associated anemia who require RBC transfusions.
More news on: Celgene Corporation, Acceleron Pharma Inc., Healthcare stocks news,